Interestingly, donor SUT036022, which had strong binding to both the RSC3 wild-type and mutant glycoproteins at late infection timepoints, showed a CD4-binding-site phenotype preceding the development of heterologous neutralization with N332/V3 bnAb specificity, which disappeared later in infection (Fig. 4f). Here, CD4 is linked to infection.